Novartis
Manufacturing · Switzerland · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Lichtstrasse 35, Basel, Basel-City, 4056...Phone Number
+41613241111Website
www.novartis.comRevenue
$56.7 BillionStock Symbol
NVSIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
3
4
2
1
1
About Novartis
Novartis is a global pharmaceutical manufacturer headquartered in Switzerland, specializing in developing and producing innovative medications and healthcare solutions. The company focuses on research and development of treatments across multiple therapeutic areas to address various medical conditions and improve patient outcomes worldwide. Novartis maintains a significant presence in scientific research, with extensive operations spanning across Europe, North America, Asia, and other global regions.Explore more
Novartis Org Chart
TN
Head of Financial Reporting Accounting, Novar...
FM
Group Planning, Reporting & Digital Finance H...
SA
Supervisor, General Ledger & Product Cost Con...
WT
Controller
WH
KPI Controller
VV
Lacan Refs Financial Controller
HS
Financial Controller
VP
Credit Controller
TS
Financial Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Novartis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Novartis launches new products
Check if Novartis has recently received funding, and reach out quickly before it becomes old news!
Novartis, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Novartis recently announced quarterly report
Funding: Get notified immidiatlly once Novartis has new funding data
Congratulate Masked Content for being promoted to Masked Content at Novartis
Website visits: Recent activity has been detected on your website
Click to see if Novartis had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Novartis is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Explore company insights
Get a deeper look into Novartis's structure, leadership, and market position:
Company Profile Activity
Activity Insights
Novartis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Novartis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Novartis.
Novartis Tech Stack
A closer look at the technologies used by Novartis
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
Novartis News & Media
Novartis (NVS) Just Handed Monte Rosa (GLUE) A $50M Milestone
On September 8, Monte Rosa Therapeutics (NASDAQ:GLUE) announced that Novartis (NYSE:NVS), its partner on a VAV1-targeted drug, had dosed the first patient in a Phase 2 trial of MRT-6160 (DDY391) for people with Sjögren’s disease. That single clinical checkpoint triggers a $50 million payment to Monte Rosa and marks just the first step in a […]Chiron Real Estate (XRN) Turns Second Quarter Into A Pivot Point
On August 5, Chiron Real Estate Inc. (NYSE:XRN) posted second quarter 2026 results that read like two different companies stitched together. Net income attributable to common stockholders jumped to $63.3 million, or $4.78 per diluted share, a sharp reversal from a $0.8 million loss a year earlier. Yet funds from operations slipped to $0.88 per […]Novartis's $30 Billion Deal Spree Triggers a Boardroom Reckoning
A major shareholder wants tighter oversight after pipeline failures exposed the cost of acquisition-led growth.Novartis investors turn spotlight on M&A after trial setbacks
LONDON/ZURICH, Sept 11 (Reuters) - Novartis investors are set to step up scrutiny of the Swiss group's dealmaking strategy after setbacks to drugs it acquired through mergers and acquisitions hit its shares, raising concerns about its pipeline. Eight shareholders told Reuters that muscle-wasting disorder drug del-desiran's failure in a late-stage study, the second major trial setback for Novartis in days, raised questions over last year's $12 billion Avidity purchase and other acquisitions.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Novartis
Sign Up For FreeTo access detailed company insights
Novartis is a global pharmaceutical manufacturer headquartered in Switzerland, specializing in developing and producing innovative medications and healthcare solutions. The company focuses on research and development of treatments across multiple therapeutic areas to address various medical conditions and improve patient outcomes worldwide. Novarti... Read More
